StocksDeepDive
Snapshot · All Ordinaries · generated 2026-09-26 00:45 UTC

BLS.AX — BLS Pharmaceuticals Limited

UNDERVALUED (MOS +39.4%) · Quality 55/100

Price
1.03
Intrinsic value
1.7
Margin of safety
+39.4%
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
40
Quality
55
Psychology
12
Discovery
42.2
price/volume attention only
Moat score
71.2
erosion: none

Value Score: top 31% of All Ordinaries · Quality: bottom 49%

Open the interactive Deep Dive for BLS.AX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BLS.AX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is BLS.AX undervalued?

As of 2026-09-26, BLS.AX trades at 1.03 against a computed intrinsic value of 1.7 (+39.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is BLS Pharmaceuticals Limited's Value Score?

BLS Pharmaceuticals Limited's Value Score is 40 as of 2026-09-26 - it combines value, quality, crowd psychology and market attention into one number.